A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC

A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC

Abstract Our previous work identified a 13-gene miRNA signature predictive of response to the epidermal growth factor receptor (EGFR) inhibitor, erlotinib, in Non-Small Cell Lung Cancer cell lines. Bioinformatic analysis of the signature showed a functional convergence on TGFβ canonical signalling....

Full description

Saved in:
Bibliographic Details
Main Authors: Madeline Krentz Gober, James P. Collard, Katherine Thompson, Esther P. Black
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/63a108947c5040c98b9e1ac1ac2632b6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items